458
A. J. Brouwer et al.
PAPER
Sulfonyl Azides 2a–f; General Procedure
ESI-MS: m/z (%) = 415 [M + H]+, 437 [M + Na]+, 453 [M + K]+.
A solution of NaN3 (195 mg, 3.00 mmol) in H2O (10 mL) was added
dropwise to a solution of the sulfonyl chloride 4a–f (3 mmol) in
acetone (15 mL) and DMF (15 mL). The reaction was stirred at r.t.
for up to 1 h. After evaporation of acetone, H2O (200 mL) was add-
ed and the product precipitated. The mixture was filtered and the
residue was washed with 5% NaHCO3 soln (10 mL), H2O (50 mL),
and dried in vacuo. Sulfonyl azides 2a–f were all obtained as white
solids.
Anal. Calcd for C20H22N4O4S: C, 57.96; H, 5.35; N, 13.52. Found:
C, 57.77; H, 5.28; N, 13.39.
2d (Derived from Fmoc-phenylalanine)17
The reaction (3.0 mmol scale) was carried out using H2O (30 mL),
acetone (20 mL), and DMF (40 mL) as solvents.
Yield: 1.37 g (99%); Rf = 0.56 (MeOH–CH2Cl2, 1:99); mp 168 °C.
IR (KBr): 2131 (s) cm–1.
2a (Cbz-Tau-N3)
1H NMR (300 MHz, THF-d8,): d = 2.95 (dd, 1 H, CHaPh,
Jgem = 13.6 Hz, Jvic = 5.8 Hz), 3.03 (dd, 1 H, CHbPh, Jgem = 13.6 Hz,
Jvic = 8.2 Hz), 3.71 (dd, 1 H, CHaSO2, Jgem = 14.7 Hz, Jvic = 3.9 Hz),
3.88 (dd, 1 H, CHbSO2, Jgem = 14.7 Hz, Jvic = 8.6 Hz), 4.19 [m, 2 H,
NCH, CH (Fmoc)], 4.40 [m, 2 H, CH2 (Fmoc)], 7.01 (d, 1 H, NH),
7.15–7.81 [m, 13 H, Ar-CH (Fmoc, Ph)].
13C NMR (75 MHz, THF-d8): d = 40.0 (CH2Ph), 48.3, 50.3 [NCH,
CH (Fmoc)], 58.4 (CH2SO2), 66.7 [CH2 (Fmoc)], 120.6, 125.9,
127.4, 127.7, 128.3, 129.3, 130.3, 138.5, 142.3, 145.3 [Ar-C (Fmoc,
Ph)], 156.4 [C=O (Fmoc)].
The reaction (16.9 mmol scale) was carried out using H2O (90 mL)
and acetone (90 mL) as solvents. The acetone solution of the sulfo-
nyl chloride was added dropwise to the aq solution of NaN3. Instead
of precipitation, the reaction was worked up by evaporation of ace-
tone, followed by re-dissolving in EtOAc (250 mL) and washing
with 5% NaHCO3 (100 mL), H2O (100 mL), and brine (100 mL).
Drying over Na2SO4 and evaporation of EtOAc afforded the sulfo-
nyl azide.
Yield: 4.3 g (90%); Rf = 0.63 (MeOH–CH2Cl2, 1:99); mp 78 °C.
IR (KBr): 2150 (s) cm–1.
1H NMR (300 MHz, CDCl3): d = 3.55 (m, 2 H, CH2SO2), 3.72 (m,
2 H, NCH2), 5.12 (s, 2 H, CH2Ph), 5.36 (br s, 1 H, NH), 7.35 (s, 5
H, Ar-CH).
ESI-MS: m/z (%) = 463 [M + H]+, 485 [M + Na]+, 501 [M + K]+,
925 [2M + H]+.
Anal. Calcd for C24H22N4O4S: C, 62.32; H, 4.79; N, 12.11. Found:
C, 62.40; H, 4.75; N, 12.03.
13C NMR (75 MHz, CDCl3): d = 35.7 (NCH2), 55.2 (CH2SO2), 67.2
(OCH2Ph), 128.1, 128.4, 128.6, 135.9 (Ar-C), 156.1 [C=O (Cbz)].
2e (Derived from Cbz-phenylalanine)
ESI-MS: m/z (%) = 285 [M + H]+, 307 [M + Na]+, 323 [M + K]+,
The reaction (3.8 mmol scale) was carried out using H2O (19 mL)
and acetone (50 mL) as solvents. The reaction and workup were per-
formed using the same procedure as for 2a.
569 [2M + H]+.
Anal. Calcd for C10H12N4O4S: C, 42.25; H, 4.25; N, 19.71. Found:
C, 42.32; H, 4.21; N, 19.66.
Yield: 1.28 g (90%); Rf = 0.48 (MeOH–CH2Cl2, 1:99); mp 141 °C.
IR (KBr): 2137.57 (s) cm–1.
1H NMR (300 MHz, CDCl3): d = 3.02 (m, 2 H, CHCH2Ph), 3.47
(dd, Jgem = 14.8 Hz, Jvic = 4.4 Hz, 1 H, CHCHaSO2), 3.71 (dd,
Jgem = 14.8 Hz, Jvic = 7.7 Hz, 1 H, CHCHbSO2), 4.32 (m, 1 H,
NCH), 5.09 (s, 2 H, OCH2Ph), 5.23 (d, 1 H, NH), 7.15–7.38 [m, 10
H, Ar-CH (Cbz, Ph)].
2b (Fmoc-Tau-N3)17
The preparation (2.95 mmol scale) was carried out in the absence of
DMF.
Yield: 1.02 g (92%); Rf = 0.54 (MeOH–CH2Cl2, 1:99); mp 118 °C.
IR (KBr): 2141 (s) cm–1.
13C NMR (75 MHz, CDCl3): d = 39.3 (CHCH2Ph), 49.1 (NCH),
57.2 (CH2SO2), 67.0 (OCH2Ph), 127.3, 128.0, 128.2, 128.5, 128.9,
129.2, 135.9, 136.0 [Ar-C (Ph, Cbz)], 155.4 [C=O (Cbz)].
1H NMR (300 MHz, CDCl3): d = 3.53 (m, 2 H, CH2SO2), 3.71 (m,
2 H, NCH2), 4.21 [t, 1 H, CH (Fmoc)], 4.44 [d, 2 H, CH2 (Fmoc)],
5.33 (br s, 1 H, NH), 7.29–7.78 [m, 8 H, Ar-CH (Fmoc)].
13C NMR (75 MHz, CDCl3): d = 35.7 (NCH2), 47.1 [CH (Fmoc)],
55.2 (CH2SO2), 67.1 [CH2 (Fmoc)], 120.0, 124.4, 124.9, 127.1,
127.8, 141.3, 143.6 [Ar-C (Fmoc)], 156.1 [C=O (Fmoc)].
ESI-MS: m/z (%) = 375 [M + H]+, 397 [M + Na]+, 413 [M + K]+,
749 [2M + H]+.
Anal. Calcd for C17H18N4O4S: C, 54.53; H, 4.85; N, 14.96. Found:
C, 54.60; H, 4.78; N, 14.87.
ESI-MS: m/z (%) = 473 [M + H]+, 395 [M + Na]+, 411 [M + K]+,
745 [2M + H]+.
2f (Derived from Fmoc-Ser(t-Bu)-OH)17
Scale: 1.62 mmol; yield: 0.55 g (74%); Rf = 0.73 (MeOH–CH2Cl2,
1:99); mp 103 °C.
Anal. Calcd for C17H16N4O4S: C, 54.83; H, 4.33; N, 15.04. Found:
C, 54.71; H, 4.25; N, 14.92.
IR (KBr): 2137 (s) cm–1.
2c (Derived from Fmoc-valine)17
1H NMR (300 MHz, CDCl3): d = 1.19 [s, 9 H, C(CH3)3], 3.51, 3.64
(2 m, 4 H, CH2SO2, t-BuOCH2), 4.23 [t, 1 H, CH (Fmoc)], 4.35–
4.51 [m, 3 H, CH2 (Fmoc), NCH], 5.33 (br d, 1 H, NH), 7.30–7.78
[m, 8 H, Ar-CH (Fmoc)].
13C NMR (75 MHz, CDCl3): d = 27.4 [C(CH3)3], 47.1, 47.6 [NCH,
CH (Fmoc)], 55.9 (CH2SO2), 61.7 (t-BuOCH2), 67.0 [CH2 (Fmoc)],
73.8 [C(CH3)3], 120,0, 124.9, 125.0, 127.1, 127.8, 141.3, 143.6 [Ar-
C (Fmoc)], 155.5 [C=O (Fmoc)].
Scale: 1.1 mmol; yield: 0.36 g (79%); Rf = 0.54 (MeOH–CH2Cl2,
1:99); mp 158 °C.
IR (KBr): 2139 (s) cm–1.
1H NMR (300 MHz, CDCl3): d = 0.96 [2 d, 6 H, CH(CH3)2], 2.04
[m, 1 H, CH(CH3)2], 3.49 (dd, 1 H, CHaSO2, Jgem = 14.7 Hz,
Jvic = 3.7 Hz), 3.60 (dd, 1 H, CHbSO2, Jgem = 14.7 Hz, Jvic = 8.1 Hz),
4.01 (m, 1 H, NCH), 4.22 [t, 1 H, CH (Fmoc)], 4.45 [m, 2 H, CH2
(Fmoc)], 5.04 (d, 1 H, NH), 7.29–7.77 [m, 8 H, Ar-CH (Fmoc)].
13C NMR (75 MHz, CDCl3): d = 18.1, 19.2 [CH(CH3)2], 31.5
[CH(CH3)2], 47.2 [CH (Fmoc)], 53.0 (NCH), 57.0 (CH2SO2), 66.9
[CH2 (Fmoc)], 119.0, 125.0, 127.1, 127.7, 141.3, 143.6, 143.7 [Ar-
C (Fmoc)], 155.7 [C=O (Fmoc)].
ESI-MS: m/z (%) = 459 [M + H]+, 481 [M + Na]+, 497 [M + K]+,
917 [2M + H]+.
Anal. Calcd for C22H26N4O5S: C, 57.63; H, 5.72; N, 12.22. Found:
C, 57.49; H, 5.66; N, 12.06.
Synthesis 2006, No. 3, 455–460 © Thieme Stuttgart · New York